A quick spray of medication might seem like an easy way to get thicker hair, but some folks say one sold online has left them battling sexual side effects, depression and even thoughts of suicide. Now, the U.S. Food and Drug Administration (FDA) is warning the public about the risks. The FDA warning is about… read on > read on >
Women suffering from urinary incontinence might have a greater risk of heart disease, a new study says. Women who struggle with bladder control are more likely to have risk factors associated with heart health problems, including type 2 diabetes and high cholesterol, researchers reported in the Journal of Preventive Medicine. They also are more likely… read on > read on >
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment read on >
The Trump administration is expected to take new steps to remove artificial food dyes from the U.S. food supply, officials say. Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary are expected to share more details on Tuesday, CNN reported. This follows a major move by the U.S. Food… read on > read on >
The U.S. Food and Drug Administration (FDA) may soon hand off routine food safety inspections to state and local officials, multiple federal health officials told CBS News. These changes are not final and could require approval and funding from Congress. Some FDA employees have been discussing a handoff for years. The goal is to free… read on > read on >
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hoping to bring the first GLP-1 weight-loss pill to market, The Wall Street… read on > read on >
Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy read on >
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib read on >
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury. The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated Press reported. The pill was in early testing to help determine the best… read on > read on >
Gun violence is bad for dental health, a new study says. More specifically, people are less likely to go to the dentist in neighborhoods with higher levels of firearm violence, researchers report in the American Journal of Preventive Medicine. These neighborhoods subsequently experience higher rates of tooth loss. And these effects increase: For every additional… read on > read on >
